Navigation Links
UC San Diego researchers identify factor boosting leukemia's aggressiveness
Date:10/22/2010

Chronic lymphocytic leukemia (CLL) cells survive and thrive not just by their own innate wiles, but by also acquiring aid and support from host cells in their surrounding environment. In a paper published online this week in The Proceedings of National Academy of Sciences, an international team of researchers led by cancer specialists at the University of California San Diego School of Medicine and the Moores UCSD Cancer Center identify a particular relationship that can promote notably aggressive leukemias and lymphomas.

"The microenvironment is the term used to describe the cells that cluster around CLL cells in the lymph nodes, spleen and bone marrow. These cells secrete factors that can protect CLL cells from dying," said Thomas J. Kipps, MD, PhD, Evelyn and Edwin Tasch Chair in Cancer Research, Professor of Medicine, Deputy Director of Research Operations at the Rebecca and John Moores UCSD Cancer Center and senior co-author of the paper with Michael Karin, PhD, Distinguished Professor of Pharmacology in UCSD's Laboratory of Gene Regulation and Signal Transduction.

Kipps, Karin and colleagues from Iowa, The Netherlands and Taiwan looked specifically at a protein called B-cell activating factor or BAFF, which is produced in high levels by "nurselike cells" in the CLL microenvironment. Nurselike cells are a subset of blood cells in CLL patients that help cancer cells avoid apoptosis or natural cell death. Kipps and colleagues first described this relationship in 2000.

The researchers found that BAFF interacts with a gene linked to leukemogenesis the development of leukemia called c-MYC. Normal MYC genes help regulate cell proliferation, but when upregulated or increased by mutations, c-MYC can promote more aggressive leukemias and lymphomas. To what degree this relationship influences CLL the most common form of adult leukemia remains unknown, though Kipps said the findings suggest therapeutic promise.

"We found that BAFF can upregulate expression of c-MYC in CLL cells and that patients who have CLL cells with high levels of c-MYC have aggressive disease," said Kipps. "These findings may lead to improvements in our ability to treat patients with CLL, either by blocking the effect of BAFF on CLL cells or inhibiting the signaling pathways triggered by BAFF that can lead to upregulation of MYC."


'/>"/>

Contact: Scott Lafee
slafee@ucsd.edu
619-543-6163
University of California -- San Diego
Source:Eurekalert

Related medicine news :

1. La Jolla Institute to develop San Diegos first center for RNAi genomics research
2. UC San Diego partners with Mozambique University to deliver quality health care
3. UC San Diego researcher awarded $3.8 million for new path to breast cancer therapy
4. Type 1 diabetes research at UC San Diego gets $5 million boost
5. UC San Diegos Karin receives prestigious Harvey Prize
6. APA presents latest research on same-sex marriage at annual convention in San Diego
7. UC San Diego researchers find cause of metabolic disease -- and possible cure
8. UC San Diego receives major clinical and translational science award
9. UC San Diego to lead new malaria research center in South America
10. World Renowned Total Artificial Heart Pioneer Dr. Jack Copeland Joins Faculty at UC San Diego
11. Nurtur Unveils the Third Dimension in Healthcare at SHRM 2010 Conference in San Diego
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2016)... (PRWEB) , ... May 28, 2016 , ... SuperCloset is ... all too well the day to day issues, struggles and obstacles veterans’ need to ... Helping Veterans Grow Project provides active or retired military veteran(s) with a donated SuperCloset ...
(Date:5/27/2016)... Angeles, CA (PRWEB) , ... May 27, 2016 , ... ... of Health, so it is not surprising that bariatric surgery has received increased attention ... Business Journal explains. Of course, when it comes to weight loss, most people are ...
(Date:5/27/2016)... ... May 27, 2016 , ... With over 60 percent of ... demand for a sustainable product to aid in the rehabilitation process has steadily increased. ... recovery of individuals with hemiplegia due to stroke. , Ekso Bionics has now received ...
(Date:5/27/2016)... , ... May 27, 2016 , ... ... installment is bolstered by inspiring human interest stories, courtesy of leaders in the ... and tech within the industry, from leading advocates and associations—namely Jones & Bartlett ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research commissioned ... dogs straight off the grill. Of the 90 percent of Americans who say they ... hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving (9 ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... WASHINGTON , May 26, 2016 ... Microspheres, Associated With Both Cost Savings and ... BTG plc (LSE: BTG), an international specialist healthcare ... data at the 21st Annual Meeting of ISPOR ... that treatment of hepatocellular carcinoma (HCC) using yttrium-90 ...
(Date:5/25/2016)... GERMANTOWN, Maryland , May 25, ... Therawis bedient dringenden Bedarf ... QIAGEN N.V. (NASDAQ: QGEN ; ... Lizenz- und Entwicklungsvereinbarung mit Therawis Diagnostics GmbH zur ... eingegangen zu sein. Ein erstes Projekt wird die ...
(Date:5/25/2016)... CORAL SPRINGS, Florida , May 25, 2016 /PRNewswire/ ... Marijuana Business Conference & Expo earlier this month, the ... undeniable. As revenues continue to climb into the billions, ... to the newly released 4th Edition State of Legal ... New Frontier, a cannabis-focused data-analysis firm, much of the ...
Breaking Medicine Technology: